• Study reports abnormally high VTE and high bleed risk in critically ill COVID-19 patients and calls for more effective prevention strategies.
  • Clinicians at NHS hospitals are supporting the care of COVID-19 patients with the use of geko™ devices to reduce the risk of blood clots in the most at risk patients.
Learn more Contact us

Partner With Us

Chronic wound healing through clinical partnerships 2022/23

We are seeking senior tissue viability nurses, willing to embrace and drive innovation advance in leg ulcer healing, to join our Partner-With-Us program.

The Partner-With-Us program coincides with the recent publication of our multi-centre, randomised self-controlled trial (RCT) that reports double the rate of healing in venous leg ulcer patients versus compression therapy alone.

A transformative innovation, the geko™ device is a small, self-adhesive, wearable neuromuscular electro-stimulator (NMES) that is applied to the skin just below the knee, over the head of the fibula. It delivers a gentle intermittent electrical pulse, once per second, to the common peroneal nerve. This elicits a muscular twitch that activates the venous muscle pumps of the leg and foot, increasing venous, arterial, and microvascular blood flow – transporting oxygenated blood to the wound bed and edge to promote wound healing.

In addition to the benefit of better patient outcomes and the release of significant costs saving for primary care, using the devices, TVNs keen to join the Partner-With-Us program – to drive innovation advance – will gain:

  • Early access to evaluate the geko™ device
  • RCN accredited user training
  • The opportunity/option – through a comprehensive handrail of support – to generate and present patient use data at local and national level.

If you would like to know more about the Partner-With-Us program, and what the geko™ device can do for your patients, please complete the contact form below. We look forward to hearing from you.

    Healthcare Professional information

    Location information